


Searching News Database: counterfeit
HSMN NewsFeed - 20 Aug 2025
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
HSMN NewsFeed - 23 Jul 2018
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution
HSMN NewsFeed - 29 Jun 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
HSMN NewsFeed - 20 Jun 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
HSMN NewsFeed - 15 May 2018
Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg
Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg
HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
HSMN NewsFeed - 26 Apr 2017
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
HSMN NewsFeed - 5 May 2016
Applied DNA Sciences Appoints Bob Miglani as Chief of Business Development
Applied DNA Sciences Appoints Bob Miglani as Chief of Business Development
HSMN NewsFeed - 13 Apr 2016
Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
HSMN NewsFeed - 17 Sep 2015
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
HSMN NewsFeed - 21 Nov 2013
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%)
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%)
HSMN NewsFeed - 25 Jun 2013
Dr. Larry Hsu, Impax Laboratories President and Chief Executive Officer, to Retire
Dr. Larry Hsu, Impax Laboratories President and Chief Executive Officer, to Retire
HSMN NewsFeed - 23 Jun 2008
NanoGuardian Client Receives FDA Approval for Its Nanoencryption Technology
NanoGuardian Client Receives FDA Approval for Its Nanoencryption Technology
HSMN NewsFeed - 14 Nov 2007
Aspen Technology Appoints James Hintlian to Launch Pharmaceuticals Business Unit
Aspen Technology Appoints James Hintlian to Launch Pharmaceuticals Business Unit
HSMN NewsFeed - 7 Mar 2007
Authentix(R) Partners with AstraZeneca to Protect Drug Supply with Unit-Level Mass Serialisation
Authentix(R) Partners with AstraZeneca to Protect Drug Supply with Unit-Level Mass Serialisation
Additional items found! 35
Members Archive contains
35 additional stories matching:
counterfeit
(Password required)
counterfeit
(Password required)
